Kabivit

Colecalciferol, the active ingredient in Kabivit, is a vitamin D presented as a nutritional supplement for oral use. It helps correct vitamin D deficiency and supports calcium balance, bone mineralization, and overall skeletal health in children and adults at risk of hypocalcemia.

GNH USA supplies Kabivit as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for health‑care providers across multiple regions, including Europe, Asia and Africa.

Kabivit (colecalciferol) is used to address disorders of vitamin D metabolism and related calcium imbalance. - Vitamin D deficiency: restores adequate serum 25‑hydroxyvitamin D levels to support normal calcium absorption. - Hypocalcemia: increases intestinal calcium absorption to raise serum calcium concentrations. - Bone health support: promotes bone mineralization and helps maintain skeletal integrity in at‑risk populations.

Colecalciferol is generally well tolerated, but some individuals may experience adverse reactions. Common Side Effects: - Hypercalcemia: elevated blood calcium levels causing nausea or weakness. - Gastrointestinal discomfort: mild abdominal pain or constipation. - Headache: transient mild headache. Serious or Rare Side Effects: - Severe hypercalcemia: confusion, arrhythmia, or renal impairment. - Allergic reaction: rash, itching, or swelling of the face and throat. - Kidney stones: formation due to excess calcium.

When using Kabivit, certain precautions should be observed to ensure safety and effectiveness. - Assess baseline vitamin D status: measure serum 25‑hydroxyvitamin D before initiating therapy. - Monitor calcium levels: periodic testing is advised in patients at risk of hypercalcemia. - Avoid excessive dosing: high doses can lead to toxicity, especially in renal impairment. - Pregnancy and lactation: use only if prescribed after risk‑benefit evaluation. - Drug interactions: review concomitant medications that affect calcium or vitamin D metabolism. - Store at ambient temperature: keep below 25 °C in the original container, protect from moisture and light.

Colecalciferol may interact with several medicines, altering its efficacy or safety. Major Interactions (Avoid): - Thiazide diuretics: can increase risk of hypercalcemia when combined with high‑dose vitamin D. - Vitamin D analogues (e.g., calcitriol): concurrent use may cause excessive calcium levels. - Aluminum‑containing antacids: reduce absorption of vitamin D. Moderate Interactions (Monitor Closely): - Orlistat: may decrease oral absorption of vitamin D, requiring dose adjustment. - Corticosteroids: can impair vitamin D metabolism, potentially reducing therapeutic effect. - Anticonvulsants (e.g., phenytoin, phenobarbital): increase vitamin D catabolism, possibly necessitating higher doses.